Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis).
Neurol Med Chir (Tokyo). 2012.
PMID: 22870528
No abstract available.
Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1997 | 1 |
| 2012 | 2 |
| 2014 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 2 |
Search Results
12 results
Results by year
Citations
2
articles
found by citation matching
Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan.
Clin Neurol Neurosurg. 1997.
PMID: 9409446
No abstract available.
Search results
Page 1
Adult Moyamoya Disease and Syndrome: Current Perspectives and Future Directions: A Scientific Statement From the American Heart Association/American Stroke Association.
Stroke. 2023 Oct;54(10):e465-e479. doi: 10.1161/STR.0000000000000443. Epub 2023 Aug 23.
Stroke. 2023.
PMID: 37609846
Free article.
Review.
Adult moyamoya disease and syndrome are rare disorders with significant morbidity and mortality. ...Despite recent advancements, there are still many unresolved questions about moyamoya disease and syndrome, including lack of unified diagnostic criteri …
Adult moyamoya disease and syndrome are rare disorders with significant morbidity and mortality. ...Despite recent advancement …
2021 Japanese Guidelines for the Management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society.
Neurol Med Chir (Tokyo). 2022 Apr 15;62(4):165-170. doi: 10.2176/jns-nmc.2021-0382. Epub 2022 Feb 22.
Neurol Med Chir (Tokyo). 2022.
PMID: 35197402
Free PMC article.
No abstract available.
Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis).
Neurol Med Chir (Tokyo). 2012;52(5):245-66. doi: 10.2176/nmc.52.245.
Neurol Med Chir (Tokyo). 2012.
PMID: 22870528
No abstract available.
Spontaneous occlusion of the circle of Willis in children: pediatric moyamoya summary with proposed evidence-based practice guidelines. A review.
J Neurosurg Pediatr. 2012 Apr;9(4):353-60. doi: 10.3171/2011.12.PEDS1172.
J Neurosurg Pediatr. 2012.
PMID: 22462697
Review.
The arteriopathy can present as an isolated medical condition, affecting both sides of the brain ("moyamoya disease") or can be unilateral or found in association with systemic disorders ("moyamoya syndrome"). ...While acknowledging these limitations, in this …
The arteriopathy can present as an isolated medical condition, affecting both sides of the brain ("moyamoya disease") or can b …
Treatment of ruptured aneurysms of the choroidal collateral system in moyamoya disease: a systematic review and data analysis.
J Neurosurg. 2021 Aug 27;136(3):637-646. doi: 10.3171/2021.1.JNS203936. Print 2022 Mar 1.
J Neurosurg. 2021.
PMID: 34450582
Review.
OBJECTIVE: Moyamoya disease (MMD) is a chronic, progressive steno-occlusive condition of the distal internal carotid arteries of unknown etiology. ...Aneurysm treatment with revascularization as the initial treatment strategy led to aneurysm regression …
OBJECTIVE: Moyamoya disease (MMD) is a chronic, progressive steno-occlusive condition of the distal internal carotid arteries …
Association of moyamoya vasculopathy with autoimmune disease: a systematic review and pooled analysis.
Neurosurg Rev. 2023 Sep 2;46(1):220. doi: 10.1007/s10143-023-02123-z.
Neurosurg Rev. 2023.
PMID: 37658996
Despite more than six decades of extensive research, the etiology of moyamoya disease (MMD) remains unknown. Inflammatory or autoimmune (AI) processes have been suggested to instigate or exacerbate the condition, but the data remains mixed. The objective of the pres …
Despite more than six decades of extensive research, the etiology of moyamoya disease (MMD) remains unknown. Inflammatory or a …
Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan.
Clin Neurol Neurosurg. 1997 Oct;99 Suppl 2:S238-40.
Clin Neurol Neurosurg. 1997.
PMID: 9409446
No abstract available.
Complications associated with combined direct and indirect bypass in Moyamoya Disease: A meta-analysis.
Neurosurg Rev. 2024 Jan 20;47(1):58. doi: 10.1007/s10143-024-02285-4.
Neurosurg Rev. 2024.
PMID: 38244093
Review.
Bypass revascularization helps prevent complications in Moyamoya Disease (MMD). To systematically review complications associated with combined direct and indirect (CB) bypass in MMD and analyze differences between the adult and pediatric populations. A systematic l …
Bypass revascularization helps prevent complications in Moyamoya Disease (MMD). To systematically review complications associa …
Chemical and perfusion markers as predictors of moyamoya disease progression and complication types.
Sci Rep. 2024 Jan 2;14(1):56. doi: 10.1038/s41598-023-47984-y.
Sci Rep. 2024.
PMID: 38167529
Free PMC article.
To investigate the association between chemical markers (triglyceride, C-reactive protein (CRP), and inflammation markers) and perfusion markers (relative cerebral vascular reserve (rCVR)) with moyamoya disease progression and complication types. A total of 314 pati …
To investigate the association between chemical markers (triglyceride, C-reactive protein (CRP), and inflammation markers) and perfusion mar …
Five-Year Outcomes of Medical Management Alone for Adult Patients with Ischemic Moyamoya Disease without Cerebral Misery Perfusion.
Cerebrovasc Dis. 2022;51(2):158-164. doi: 10.1159/000518725. Epub 2021 Sep 9.
Cerebrovasc Dis. 2022.
PMID: 34518462
INTRODUCTION: No clear guidelines for treating adult patients with ischemic moyamoya disease (MMD) without cerebral hemodynamic compromise such as misery perfusion have been established. ...
INTRODUCTION: No clear guidelines for treating adult patients with ischemic moyamoya disease (MMD) without cerebral hem …
Cite